Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Medibank on its acquisition of a non-controlling 33.4% economic interest in the Myheath Medical Group, a leading operator of primary care clinics.

This strategic acquisition by Medibank recognises the vital role of GPs in the community and the positive impact they have on the healthcare system. 

A cross-practice Corrs team led by partners Sandy Mak (Corporate), Mark McCowan (Competition), Rommel Harding-Farrenberg (Banking and Finance), Stephen Price (Employment), Eugenia Kolivos (Intellectual Property), Helen Clarke (Intellectual Property) and Nathaniel Popelianski (Property and Real Estate) advised Medibank on all aspects of the transaction, from structuring and due diligence to the signing of the transaction documents.  

Corrs will continue to advise Medibank up to completion of the transaction, which is expected to take place in March 2021. 

Commenting on the matter, Corrs lead Partner Sandy Mak said: “It has been a pleasure and privilege to work on another strategic transaction with Medibank. It was a great team effort involving a wide range of Corrs practice groups across the country.”


This publication is introductory in nature. Its content is current at the date of publication. It does not constitute legal advice and should not be relied upon as such. You should always obtain legal advice based on your specific circumstances before taking any action relating to matters covered by this publication. Some information may have been obtained from external sources, and we cannot guarantee the accuracy or currency of any such information.